Xin Tao is a member of BM's North America Steering Committee for Healthcare & Life Sciences and heads our US Food and Drug Law Practice. A former research scientist, Xin brings a deep understanding of the complex scientific issues that relate to the US legal compliance and government enforcement issues, enabling him to help clients with all phases of product development, manufacturing, and marketing. Xin's practice focuses on advising high-growth companies and investors in life science, healthcare, E-commerce, and technology industries globally. As part of the firm's US Government Enforcement Practice, he has represented many global companies during high-stake US government investigations (including actions initiated by the US Congress, U.S. Department of Justice (DOJ), and U.S. Food and Drug Administration (FDA)) around the world. Xin also has a strong track record in US consumer product recall matters, and with a deep understanding of the intricacies involved in navigating the complex and interrelated legal and scientific issues, Xin can creatively and effectively represent companies in these bet-the-company cases. Xin was selected to serve on the 2023 Law360 Life Sciences Editorial Advisory Board, and also nominated as a Thomson Reuters Stand-out Lawyer based on its 2024 client survey.